Author:
Rothenberg M.L.,Benedetti J.K.,Macdonald J.S.,Seay T.E.,Neubauer M.A.,George C.S.,Tanaka M.S.,Giguere J.K.,Pruitt B.T.,Abbruzzese J.L.
Reference23 articles.
1. Cancer statistics, 2000;Greenlee;CA Cancer J Clin,2000
2. Chemotherapy for resectable and advanced pancreatic cancer;Berlin;Oncology (Huntington),2001
3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997
4. 5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil;Baccanari;Proc Natl Acad Sci USA,1993
5. Spector T. 5-ethynyluracil (776C85): modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing advanced colorectal carcinoma;Cao;Cancer Res,1994
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献